Australian Genomic Technologies Association conference

Thursday, 21 August, 2014

The 14th Australasian Genomic Technologies Association (AGTA) conference will be held at the Crown Promenade, Melbourne, Australia, Sunday 12 to Wednesday 15 October 2014.

The AGTA conference (formerly known as AMATA) is Australia’s foremost genomic technology conference. This year brings an exciting program that spans a diversity of research topics utilising cutting-edge genomic technologies. Major themes include clinical genomics, functional genomics, bioinformatics, metagenomics, cancer genomics, epigenomics and plant genomics. The conference will also host a workshop focusing on the application of clinical genomics, an exciting area currently undergoing a major expansion in Australia.

Further features of the conference program include new student social functions and the regular conference dinner to be held at the Arts Centre of Melbourne under the iconic spire that has featured as part of this year’s conference logo.

The AGTA conference enables the opportunity for interaction between biologists, bioinformaticians and technologists. This unique mix is one of the reasons that the Australian genomics community has a dynamic cross-disciplinary and innovative approach to genomic analysis and is at the forefront of analysis tools for new types of ’omics data.

The conference will host an outstanding list of international and national speakers plus has engaged industry to showcase the best in new genomic technologies. There will be opportunity for some great networking and cutting-edge science in the heart of the “most livable city” in the world.

For more details and to register to attend, visit: agtaconference.org.

Related News

Virologist receives GSK Award for AI-based disease detection

Professor Edward Holmes has received the 2025 GSK Award for Research Excellence for his...

WA Govt creates Science and Technology Council

The council will offer independent advice on emerging opportunities and challenges, promoting...

Billion-dollar deal for UQ's molecular clamp vaccine tech

Sanofi has entered into an agreement to acquire Vicebio, a biotech company formed in 2018 to...


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd